In contrast, many BIA-ALCLs show the expression of CD15, CD13, and CD33 bone marrow markers, which may be related to the up-regulation of genes involved in myeloid cell differentiation recently reported in BIA-ALCL. The gene discussed is CD33; the disease is anaplastic large cell lymphoma.